Takeyuki Yatsu

1.3k citations

64 papers · 1.1k indexed · h-index 19

Pulmonary and Respiratory Medicine top 5%
Social Psychology top 2%
Molecular Biology
Cardiology and Cardiovascular Medicine top 10%
Endocrine and Autonomic Systems top 5%

Co-authors: Atsuo Tahara Junko Tsukada Yuichi Tomura Wataru Uchida Koh‐ichi Wada Toshiyuki Kusayama Akihiro Tanaka Noe Ishii
Topics: Neuroendocrine regulation and behavior (37 papers)Electrolyte and hormonal disorders (34 papers)Circadian rhythm and melatonin (18 papers)
Cited by: Endocrine and Autonomic Systems Social Psychology Pulmonary and Respiratory Medicine
Journals: Journal of Pharmacology and Experimental Therapeutics British Journal of Pharmacology Cardiovascular Research
Partner nations: Japan Norway United Kingdom

In The Last Decade

Takeyuki Yatsu

64 papers receiving 971 citations

Peers

Countries citing papers authored by Takeyuki Yatsu

Since Specialization

Citations

This map shows the geographic impact of Takeyuki Yatsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeyuki Yatsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeyuki Yatsu more than expected).

Fields of papers citing papers by Takeyuki Yatsu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takeyuki Yatsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeyuki Yatsu. The network helps show where Takeyuki Yatsu may publish in the future.

Co-authorship network of co-authors of Takeyuki Yatsu

This figure shows the co-authorship network connecting the top 25 collaborators of Takeyuki Yatsu. A scholar is included among the top collaborators of Takeyuki Yatsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takeyuki Yatsu. Takeyuki Yatsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effects of High Glucose on AVP-Induced Hyperplasia, Hypertrophy, and Type IV Collagen Synthesis in Cultured Rat Mesangial Cells 2012 ·Endocrine Research ·Atsuo Tahara,Junko Tsukada,Yuichi Tomura,Takeyuki Yatsu,Masayuki Shibasaki	12
2	Optimization of (4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepine-5-ylidene)acetamide derivatives as arginine vasopressin V2 receptor agonists and discussion of their binding modes 2009 ·Bioorganic & Medicinal Chemistry ·(unknown),Hiroyuki Koshio,Masaya Orita,(unknown),(unknown),(unknown),(unknown),Takeyuki Yatsu,Shuichi Sakamoto,Shin‐ichi Tsukamoto	1
3	Vasopressin increases type IV collagen production through the induction of transforming growth factor-beta secretion in rat mesangial cells 2008 ·Pharmacological Research ·Atsuo Tahara,Junko Tsukada,Yuichi Tomura,Takeyuki Yatsu,Masayuki Shibasaki	26
4	Binding and Signal Transduction Characteristics of the Nonpeptide Vasopressin V<sub>1A</sub> Receptor-Selective Antagonist YM218 in Cultured Rat Mesangial Cells 2006 ·Pharmacology ·Atsuo Tahara,Junko Tsukada,Yuichi Tomura,Toshiyuki Kusayama,Kazuhiro Momose,Nobuaki Taniguchi,Takeshi Suzuki,Takeyuki Yatsu,Masayuki Shibasaki	4
5	Effects of YM218, a nonpeptide vasopressin V1A receptor-selective antagonist, on human vasopressin and oxytocin receptors 2004 ·Pharmacological Research ·Atsuo Tahara,Junko Tsukada,Yuichi Tomura,Toshiyuki Kusayama,Koh‐ichi Wada,Noe Ishii,Nobuaki Taniguchi,Takeshi Suzuki,Takeyuki Yatsu,Wataru Uchida,Masayuki Shibasaki	15
6	Alterations of Renal Vasopressin V<sub>1A</sub> and V<sub>2</sub> Receptors in Spontaneously Hypertensive Rats 2003 ·Pharmacology ·Atsuo Tahara,Junko Tsukada,Yuichi Tomura,Koh‐ichi Wada,Toshiyuki Kusayama,Noe Ishii,Takeyuki Yatsu,Wataru Uchida,Nobuaki Taniguchi,Akihiro Tanaka	11
7	Pharmacological characterization of YM471, a novel potent vasopressin V1A and V2 receptor antagonist 2002 ·European Journal of Pharmacology ·Junko Tsukada,Atsuo Tahara,Yuichi Tomura,(unknown),Toshiyuki Kusayama,Noe Ishii,Motonori Aoki,Takeyuki Yatsu,Wataru Uchida,Nobuaki Taniguchi,Akihiro Tanaka	13
8	EFFECT OF CONIVAPTAN, A COMBINED VASOPRESSIN V1a AND V2 RECEPTOR ANTAGONIST, ON VASOPRESSIN-INDUCED CARDIAC AND HAEMODYNAMIC CHANGES IN ANAESTHETISED DOGS 2002 ·Pharmacological Research ·Takeyuki Yatsu	23
9	AVP-induced mitogenic responses of Chinese hamster ovary cells expressing human V 1A or V 1B receptors 1999 ·Pflügers Archiv - European Journal of Physiology ·Atsuo Tahara,Masayuki Saito,Toru Sugimoto,Yuichi Tomura,Koh‐ichi Wada,Toshiyuki Kusayama,Junko Tsukada,Noe Ishii,Takeyuki Yatsu,Wataru Uchida,Akihiro Tanaka	9
10	Pharmacology of conivaptan hydrochloride (YM087), a novel vasopressin V1A/V2 receptor antagonist 1999 ·Folia Pharmacologica Japonica ·Takeyuki Yatsu,Yuichi Tomura,Atsuo Tahara,Koh‐ichi Wada,Toshiyuki Kusayama,Junko Tsukada,Akihiro Tanaka,(unknown),Kazuo Honda	3
11	Nonpeptide Arginine Vasopressin Antagonists for Both V1A and V2 Receptors: Synthesis and Pharmacological Properties of 4'-(5-(Substituted Methylidene)-2,3,4,5-tetrahydro-1H-1-benzoazepine-1-carbonyl)benzanilide and 4'-(5-(Substituted Methyl)-2,3-dihydro-1H-1-benzoazepine-1-carbonyl)benzanilide Derivatives. 1999 ·Chemical and Pharmaceutical Bulletin ·Akira Matsuhisa,(unknown),(unknown),Takeyuki Yatsu,Akihiro Tanaka	12
12	Vasopressin increases vascular endothelial growth factor secretion from human vascular smooth muscle cells 1999 ·European Journal of Pharmacology ·Atsuo Tahara,Masayuki Saito,Junko Tsukada,Noe Ishii,Yuichi Tomura,Koh‐ichi Wada,Toshiyuki Kusayama,Takeyuki Yatsu,Wataru Uchida,Akihiro Tanaka	21
13	Pharmacological characterization of the human vasopressin receptor subtypes stably expressed in Chinese hamster ovary cells 1998 ·British Journal of Pharmacology ·Atsuo Tahara,Masayuki Saito,Toru Sugimoto,Yuichi Tomura,Koh‐ichi Wada,Toshiyuki Kusayama,Junko Tsukada,Noe Ishii,Takeyuki Yatsu,Wataru Uchida,Akihiro Tanaka	51
14	Nonpeptide Arginine Vasopressin Antagonists for Both V1A and V2 Receptors: Synthesis and Pharmacological Properties of 2-Phenyl-4'-(2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-1-carbonyl)benzanilide Derivatives. 1998 ·Chemical and Pharmaceutical Bulletin ·Akira Matsuhisa,Hiroyuki Koshio,(unknown),Nobuaki Taniguchi,Takeyuki Yatsu,Akihiro Tanaka	30
15	Pharmacological characterization of YM087, a potent, nonpeptide human vasopressin V1A and V2 receptor antagonist 1997 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Atsuo Tahara,Masayuki Saito,Toru Sugimoto,Yuichi Tomura,Koh‐ichi Wada,Toshiyuki Kusayama,Junko Tsukada,Noe Ishii,Takeyuki Yatsu,Wataru Uchida,Akihiro Tanaka	44
16	Pharmacological profile of YM087, a novel nonpeptide dual vasopressin V1A and V2 receptor antagonist, in dogs 1997 ·European Journal of Pharmacology ·Takeyuki Yatsu,Yuichi Tomura,Atsuo Tahara,Koh‐ichi Wada,Junko Tsukada,Wataru Uchida,Akihiro Tanaka,Toichi Takenaka	59
17	Nonpeptide Arginine Vasopressin Antagonists for Both V1A and V2 Receptors: Synthesis and Pharmacological Properties of 2-Phenyl-4'-((2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl)carbonyl)benzanilide Derivatives. 1997 ·Chemical and Pharmaceutical Bulletin ·Akio Matsuhisa,Akihiro Tanaka,Ken Kikuchi,Yutaka Shimada,Takeyuki Yatsu,I. YANAGISAWA	15
18	Renal effect of YM435, a new dopamine D1 receptor agonist, in anesthetized dogs 1997 ·European Journal of Pharmacology ·Takeyuki Yatsu,Yukinori Arai,Kenji Takizawa,(unknown),Masahiro Takanashi,Wataru Uchida,Osamu Inagaki,Akihiro Tanaka,Masaharu Asano,Kazuo Honda,Toichi Takenaka	13
19	4-(3,4-Dihydroxyphenyl)-1,2,3,4-tetrahydroisoquinoline Derivatives. II. Their Renal Vasodilation Activity and Structure-Activity Relationship. 1996 ·Chemical and Pharmaceutical Bulletin ·Hisashi Anan,Akihiro Tanaka,(unknown),(unknown),Takeyuki Yatsu,Takashi Fujikura	14
20	Synthesis, Resolution, and Renal Vasodilation Activity of Novel DA1 Agonists: 4-(3,4-Dihydroxyphenyl)-1,2,3,4-tetrahydroisoquinoline Derivatives. 1991 ·Chemical and Pharmaceutical Bulletin ·Hisashi Anan,Akihiro Tanaka,(unknown),(unknown),Takeyuki Yatsu,Kazuo Honda,Masaharu Asano,S. Fujita,Tsuyoshi Furuya,Takashi Fujikura	9

About Takeyuki Yatsu

Takeyuki Yatsu is a scholar working on Endocrine and Autonomic Systems, Social Psychology and Pulmonary and Respiratory Medicine, having authored 64 papers that have together received 1.1k indexed citations. Recurring topics across this work include Neuroendocrine regulation and behavior (37 papers), Electrolyte and hormonal disorders (34 papers) and Circadian rhythm and melatonin (18 papers). The work is most often cited by research in Endocrine and Autonomic Systems (178 citations), Social Psychology (474 citations) and Pulmonary and Respiratory Medicine (547 citations). Takeyuki Yatsu has collaborated with scholars based in Japan, Norway and United Kingdom. Frequent co-authors include Atsuo Tahara, Junko Tsukada, Yuichi Tomura, Wataru Uchida, Koh‐ichi Wada, Toshiyuki Kusayama, Akihiro Tanaka, Noe Ishii, Masayuki Shibasaki and Akihiro Tanaka. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, British Journal of Pharmacology and Cardiovascular Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact